Rudolf Baumgartner-arkiv - BioStock

FDA

Saniona’s CMO on the FDA Orphan Drug Designation for Tesomet in...

3 August, 2021

Saniona’s CMO on the new clinical trial with SAN711

1 July, 2021

Saniona on the positive feedback from FDA

10 March, 2021

Saniona´s CMO on the FDA’s Orphan Drug Designation for Tesomet in...

4 March, 2021